Punch & Associates Investment Management, Inc. Harvard Bioscience Inc Transaction History

Punch & Associates Investment Management, Inc.

  • $1.66 Billion
  • Q1 2024

A detailed history of Punch & Associates Investment Management, Inc. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Punch & Associates Investment Management, Inc. holds 2,772,339 shares of HBIO stock, worth $7.9 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
2,772,339
Previous 2,918,034 4.99%
Holding current value
$7.9 Million
Previous $15.6 Million 24.71%
% of portfolio
0.71%
Previous 0.96%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$4.02 - $5.39 $585,693 - $785,296
-145,695 Reduced 4.99%
2,772,339 $11.8 Million
Q4 2023

Feb 15, 2024
BUY
$4.0 - $5.49 $11.7 Million - $16 Million
2,918,034 New
2,918,034 $15.6 Million
Q3 2023

Oct 26, 2023
BUY
$4.0 - $5.82 $241,540 - $351,440
60,385 Added 2.11%
2,923,034 $12.6 Million
Q2 2023

Aug 14, 2023
SELL
$4.19 - $6.16 $354,809 - $521,628
-84,680 Reduced 2.87%
2,862,649 $15.7 Million
Q1 2023

May 15, 2023
BUY
$2.45 - $4.22 $449,060 - $773,483
183,290 Added 6.63%
2,947,329 $12.4 Million
Q4 2022

Feb 14, 2023
BUY
$2.12 - $2.86 $86,004 - $116,024
40,568 Added 1.49%
2,764,039 $7.66 Million
Q3 2022

Nov 14, 2022
BUY
$2.58 - $3.92 $178,597 - $271,358
69,224 Added 2.61%
2,723,471 $6.97 Million
Q2 2022

Aug 15, 2022
BUY
$3.28 - $6.42 $619,385 - $1.21 Million
188,837 Added 7.66%
2,654,247 $9.56 Million
Q1 2022

May 16, 2022
BUY
$5.16 - $7.14 $1.54 Million - $2.13 Million
298,635 Added 13.78%
2,465,410 $15.3 Million
Q4 2021

Feb 15, 2022
BUY
$6.37 - $8.18 $3.47 Million - $4.46 Million
545,000 Added 33.61%
2,166,775 $15.3 Million
Q3 2021

Nov 15, 2021
SELL
$6.98 - $8.47 $366,708 - $444,988
-52,537 Reduced 3.14%
1,621,775 $11.3 Million
Q2 2021

Aug 16, 2021
SELL
$5.44 - $8.4 $209,739 - $323,862
-38,555 Reduced 2.25%
1,674,312 $13.9 Million
Q1 2021

May 18, 2021
BUY
$3.91 - $6.99 $395,035 - $706,213
101,032 Added 6.27%
1,712,867 $9.35 Million
Q4 2020

Feb 16, 2021
BUY
$3.0 - $4.5 $222,105 - $333,157
74,035 Added 4.81%
1,611,835 $6.92 Million
Q3 2020

Nov 16, 2020
BUY
$2.75 - $4.2 $1.44 Million - $2.2 Million
523,000 Added 51.54%
1,537,800 $4.63 Million
Q2 2020

Aug 14, 2020
BUY
$2.12 - $3.14 $2.15 Million - $3.19 Million
1,014,800 New
1,014,800 $3.15 Million

Others Institutions Holding HBIO

# of Institutions
92
Shares Held
32.8M
Call Options Held
4K
Put Options Held
2.2K
View Full List

About HARVARD BIOSCIENCE INC

HBIO Quotes by TradingView
  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $119M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Punch & Associates Investment Management, Inc. Portfolio

Follow Punch & Associates Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Punch & Associates Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Punch & Associates Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email